The Kappa Opioid Receptor: Candidate Pharmacotherapeutic Target for Multiple Sclerosis
Multiple sclerosis (MS) afflicts millions of people worldwide. While multiple therapeutics have recently been developed and approved as treatment agents, they are not 100% effective. Recent developments investigating the endogenous opioid system involvement in MS has revealed that agonists of the ka...
Gorde:
| Egile Nagusiak: | , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
MDPI AG
2023-11-01
|
| Saila: | Drugs and Drug Candidates |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.mdpi.com/2813-2998/2/4/44 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|